201932-92-5

Basic information

• Product Name: methyl 3-(hydroxymethyl)-4-nitrobenzoate
• Synonyms: methyl 3-(hydroxymethyl)-4-nitrobenzoate
• CAS NO: 201932-92-5
• Molecular Formula: C₉H₉NO₅
• Molecular Weight: 211.17146
• Mol File: 201932-92-5.mol
• Article Data: 12

Chemical Properties

• Appearance: /
• Storage Temp.: Sealed in dry,Room Temperature
• CAS DataBase Reference: methyl 3-(hydroxymethyl)-4-nitrobenzoate(CAS DataBase Reference)
• NIST Chemistry Reference: methyl 3-(hydroxymethyl)-4-nitrobenzoate(201932-92-5)
• EPA Substance Registry System: methyl 3-(hydroxymethyl)-4-nitrobenzoate(201932-92-5)

Safety Data

• Hazardous Substances Data: 201932-92-5(Hazardous Substances Data)

Usage

General Description

Methyl 3-(hydroxymethyl)-4-nitrobenzoate is a chemical compound that belongs to the class of benzoic acid derivatives. It contains a methyl group, a hydroxymethyl group, and a nitro group attached to a benzene ring. methyl 3-(hydroxymethyl)-4-nitrobenzoate is commonly used in organic synthesis and pharmaceutical research due to its potential biological activity. It is also used as a building block in the synthesis of various pharmaceuticals and agrochemicals. The presence of the hydroxymethyl and nitro groups in the molecule makes it a versatile building block for the synthesis of diverse chemical products.

Upstream product

• 24078-21-5 methyl 3-methyl-4-nitrobenzoate 
• 4637-24-5 N,N-dimethyl-formamide dimethyl acetal 
• 148625-35-8 methyl 3-formyl-4-nitrobenzoate 

Downstream Products

• 148625-35-8 methyl 3-formyl-4-nitrobenzoate 
• 88071-90-3 3-bromomethyl-4-nitro-benzoic acid methyl ester 
• 76143-02-7 C₉H₁₁NO₃ 

Relevant articles and documents

PRODRUG-TYPE ANTICANCER AGENT USING CANCER-SPECIFIC ENZYMATIC ACTIVITY

To provide novel compounds that are promising as prodrug-type anticancer agents, a compound represented by general formula (I) or a salt thereof is provided.

NEOSEPTINS: SMALL MOLECULE ADJUVANTS

A MD-2:TLR4 complex agonist compound is disclosed whose structure corresponds to Formula (I), as defined within. Also disclosed are a method of its preparation and use, as well as a pharmaceutical composition containing the same.

Use of certain amides as probes for detection of antitubulin activity and resistance monitoring

This invention relates to methods for screening compounds for antitubulin activity, evaluation of cells for sensitivity to antitubulin drugs, resistance monitoring and quantifying tubulin using certain amides that inhibit the growth of eukaryotic cells as